ABSTRACT
In the paper a new method is presented of injured nerve fibres repair by means of the so-called fusogens. This entirely novel approach to the treatment of injuries of the central nervous system and peripheral nerves in humans may be feasible in a near future. Unquestionable advantages of these substances include their easy applicability and no undesirable side effects. What remains to be established is their mode of operation and precise therapeutic indications.
Subject(s)
Cell Fusion/methods , Central Nervous System/injuries , Neurons/pathology , Peripheral Nerve Injuries , Humans , Treatment OutcomeABSTRACT
Extracellular matrix turnover disturbances are implicated in many human diseases. Matrix Metalloproteinases (MMP) are believed to play a pivotal role in maintaining the intricate balance between extracellular matrix synthesis and degradation. These enzymes are active in the cleavage of many matrix proteins. There is evidence that matrix metalloproteinases activity changes in many pathological conditions, including inflammatory and degenerative disorders as well as tumour progression and metastases. This review focuses on the recent view on physiological and pathological function of MMPs. Authors aimed also to show the putative role of matrix metalloproteinases as a diagnostic tool in future medicine.
